Evidence map›Paper›PMID 32243307›Full record

GuidelineJournal of lower genital tract disease2020

2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.

Rebecca B Perkins, Richard S Guido, Philip E Castle, David Chelmow, Mark H Einstein, Francisco Garcia, Warner K Huh, Jane J Kim, Anna-Barbara Moscicki, Ritu Nayar and 5 more

Erratum issued 2 registry-linked trialsAbstract readPractice Guideline
In one paragraph

Guideline in Journal of lower genital tract disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 598 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
598citing papers in PubMed, 9 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04915495 naenrolling by invitationnot on this mapstarted 2023, after this paper: background citation

The Use of the LuViva Advanced Cervical Scan to Identify Women at High-Risk for Cervical Neoplasia

TypeinterventionalSponsorGuided TherapeuticsRan2023 to 2025Enrolled400ConditionsCervical DysplasiaArmsLuViva Advanced Cervical Scan
NCT06333743 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Efficacy, Acceptability, and Safety of Laser Ablation in the Treatment of High-grade Cervical Lesions: a Randomized Clinical Trial

TypeinterventionalSponsorPeking Union Medical College HospitalRan2024 to 2026Enrolled308ConditionsHigh-Grade Squamous Intraepithelial LesionsArmslaser ablation, LEEP or Conization
3 · Its place in the literature

Who cites it

598 citing papers in PubMed, 9 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Human papillomavirus-based vs. cytology for cervical cancer screening: a systematic review with meta-analysis.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2026
    Pooled it
  8. Guideline
  9. Pooled it
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. The 'see-and-treat' approach in the treatment of preneoplastic cervical lesions.European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) · 2026
    Article
  19. Article
  20. Article

538 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Rebecca B PerkinsFrom the Boston University School of Medicine/Boston Medical Center, Boston, MA.
Richard S GuidoUniversity of Pittsburgh/Magee-Women's Hospital, Pittsburgh, PA.
Philip E CastleAlbert Einstein College of Medicine, New York, NY.
David ChelmowVirginia Commonwealth University School of Medicine, Richmond, VA.
Mark H EinsteinRutgers, New Jersey Medical School, Newark, NJ.
Francisco GarciaPima County Health & Community Services, Tucson, AZ.
Warner K HuhUAB School of Medicine, Birmingham, AL.
Jane J KimHarvard T.H. Chan School of Public Health Boston, MA.
Anna-Barbara MoscickiUniversity of California, Los Angeles, CA.
Ritu NayarNorthwestern University, Feinberg School of Medicine-Northwestern Memorial Hospital, Chicago, IL.
Mona SaraiyaDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA.
George F SawayaUniversity of California, San Francisco, San Francisco, CA.
Nicolas WentzensenDivision of Cancer Epidemiology and Genetics and Division of Cancer Prevention, National Cancer Institute, Bethesda, MD.
Mark SchiffmanDivision of Cancer Epidemiology and Genetics and Division of Cancer Prevention, National Cancer Institute, Bethesda, MD.
2019 ASCCP Risk-Based Management Consensus Guidelines Committee

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedColposcopyConsensusEarly Detection of CancerFemaleHumansMiddle AgedPregnancyRisk AssessmentRisk ManagementSocieties, MedicalUterine Cervical NeoplasmsVaginal SmearsYoung Adult

Identifiers

PMID32243307
PMCPMC7147428

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.